DE VINCENTIS, ANTONIO
 Distribuzione geografica
Continente #
EU - Europa 36
AS - Asia 6
NA - Nord America 4
AF - Africa 2
OC - Oceania 1
Totale 49
Nazione #
IT - Italia 23
NL - Olanda 6
US - Stati Uniti d'America 4
CN - Cina 3
CZ - Repubblica Ceca 2
IN - India 2
SE - Svezia 2
DE - Germania 1
EG - Egitto 1
GB - Regno Unito 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
UA - Ucraina 1
YE - Yemen 1
Totale 49
Città #
Rome 21
Amsterdam 3
Shanghai 3
Boardman 2
Ciampino 2
Kolkata 2
Stockholm 2
Cairo 1
Columbus 1
Kano 1
London 1
Sanaa 1
Totale 40
Nome #
Essays on quality of therapy and impact of comorbidities in older hospitalized subjects, file 92da4b10-d9ff-49e7-a63b-b4cec22442f8 27
Reply, file d88da105-466c-4ff1-b763-e48322eef03a 4
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease, file de024af2-ba78-70dc-e053-6605fe0a0424 3
Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liver, file de024af2-c3a3-70dc-e053-6605fe0a0424 3
Predicting risk of declining functional ability in community-dwelling older people, file a9372618-fd11-406c-a521-8405c935d946 2
NAFLD FIBROSIS SCORE IS ASSOCIATED WITH CARDIOVASCULAR DISEASE IN PATIENTS UNDERGOING CORONAROGRAPHY, file de024af2-0d1a-70dc-e053-6605fe0a0424 2
Screening of obstructive sleep apnea syndrome by electronic-nose analysis of volatile organic compounds, file de024af2-799a-70dc-e053-6605fe0a0424 2
Incidence and Outcome of Pneumomediastinum in Non-ICU Hospitalized COVID-19 Patients, file 2a951383-f43b-4dfe-92df-104c3242a160 1
Gut Microbiota and Related Electronic Multisensorial System Changes in Subjects With Symptomatic Uncomplicated Diverticular Disease Undergoing Rifaximin Therapy, file 4edc52a1-8190-4802-89f2-ba5ebdde1daa 1
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid, file 8b63d21e-d5d2-4cca-806d-bccee4ae1f93 1
Liver Cirrhosis is Characterized by an Acquired Lysosomal Acid Lipase Deficiency Independent from the Etiology of Liver Disease, file de024af2-0d71-70dc-e053-6605fe0a0424 1
Prevalence of patatin-like phospholipase domain containing 3 (PNPLA3) rs738409 C/G polymorphism in patients with bona-fide post-NASH cirrhosis, file de024af2-0dd9-70dc-e053-6605fe0a0424 1
Assessment of liver function by the exhaled breath-print during chronic liver disease, file de024af2-0e45-70dc-e053-6605fe0a0424 1
Drug-drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients, file de024af2-11a5-70dc-e053-6605fe0a0424 1
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study, file de024af2-11a9-70dc-e053-6605fe0a0424 1
Long noncoding RNAs in nonalcoholic fatty liver disease and liver fibrosis: state-of-the-art and perspectives in diagnosis and treatment., file de024af2-13b5-70dc-e053-6605fe0a0424 1
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients, file de024af2-19b3-70dc-e053-6605fe0a0424 1
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES, file de024af2-a952-70dc-e053-6605fe0a0424 1
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery, file de024af2-c072-70dc-e053-6605fe0a0424 1
Totale 55
Categoria #
all - tutte 123
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202212 0 0 0 0 0 0 0 0 11 0 0 1
2022/202327 0 1 2 1 3 3 9 1 2 0 0 5
2023/202416 2 0 1 6 0 0 1 0 4 1 1 0
Totale 55